Cargando…
Pharmacokinetics of orally administered uracil in healthy volunteers and in DPD-deficient patients, a possible tool for screening of DPD deficiency
PURPOSE: Dihydropyrimidine dehydrogenase (DPD) deficiency can lead to severe toxicity in patients treated with standard doses of 5-fluorouracil (5-FU). Oral uracil administration and subsequent measurement of uracil and dihydrouracil (DHU) plasma concentrations might detect patients with DPD deficie...
Autores principales: | van Staveren, Maurice C., Theeuwes-Oonk, Barbara, Guchelaar, Henk Jan, van Kuilenburg, André B. P., Maring, Jan Gerard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3220818/ https://www.ncbi.nlm.nih.gov/pubmed/21590448 http://dx.doi.org/10.1007/s00280-011-1661-5 |
Ejemplares similares
-
Delayed Presentation of DPD Deficiency in Colorectal Cancer
por: Law, Lindsey, et al.
Publicado: (2014) -
Case report: 5-Fluorouracil treatment in patient with an important partial DPD deficiency
por: Schmitt, Antonin, et al.
Publicado: (2023) -
Reduced 5-FU clearance in a patient with low DPD activity due to heterozygosity for a mutant allele of the DPYD gene
por: Maring, J G, et al.
Publicado: (2002) -
A Simple and Rapid UPLC‐UV Method for Detecting DPD Deficiency in Patients With Cancer
por: Marin, Clémence, et al.
Publicado: (2020) -
Dihydropyrimidine dehydrogenase (DPD) polymorphisms knocking on the door
por: Donadio, Mauro Daniel Spina, et al.
Publicado: (2022)